Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Biogen Idec Names Chief Strategy Officer | Contract Pharma
Breaking News, Promotions & Moves

Biogen Idec Names Chief Strategy Officer

Koppel to lead corporate strategy and portfolio management

Adam M. Koppel, M.D., Ph.D., has been appointed senior vice president and chief strategy officer at Biogen Idec, effective May 15, 2014. Dr. Koppel will be responsible for leading corporate strategy and portfolio management, reporting to George Scangos, Ph.D., chief executive officer. He will also serve as member of the management team.
 
Dr. Koppel will join the company from Brookside Capital, the public equity affiliate of Bain Capital, where he served as a managing director since 2009. Prior to Brookside Capital, he was an associate principal of the McKinsey Healthcare Practice.
 
“With his experience as a physician, scientist and executive, Adam will be invaluable to Biogen Idec as we grow in size and complexity, bringing a unique set of capabilities to bolster our position at the intersection of medicine, science and economics,” said Dr. Scangos. “Adam is a respected biotechnology investor and industry leader, and we are thrilled to have his insight and vision to help guide our company and management team.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters